drugset / Trial / NCT04712396

A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

NCT04712396

Phase 1 Completed 11 enrolled AstraZeneca Parexel · collab
NaSingle-groupOpen-labelOther

Summary

This study will be an open-label, fixed sequence study in healthy subjects (vasectomized males and females of non-childbearing potential), performed at a single study centre.

Timeline

Start
2021-02-01
Primary completion
2021-03-25
Completion
2021-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Capivasertib Small molecule Oral
Subject Itraconazole Small molecule

Indications